Bipolar Disorder Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged between 18 and 25 years old.
- People who have a primary diagnosis of an anxiety disorder, depressive disorder, or bipolar disorder, confirmed by a specific clinical assessment tool used by the trial team.
- People diagnosed with bipolar disorder must currently be in a stable mood state or experiencing a depressive episode (not a high/elevated mood episode).
- People who own or have access to an Apple iPhone, iPad, or Android device.
Who may not be able to join:
- People with a history of a neurological condition that could affect brain function relevant to the study or affect their ability to take part (confirm with trial site).
- People who have ever been diagnosed with a psychotic disorder.
- People who are currently experiencing a hypomanic or manic episode (a period of unusually elevated or irritable mood).
- People who are currently receiving cognitive behaviour therapy (a specific type of talking therapy).
- People whose dose of a psychiatric medication has changed in the past 12 weeks.
- People who have started any form of psychotherapy in the past 12 weeks.
- People who currently have thoughts, intentions, or a plan to attempt suicide.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Jennifer Bress, Ph.D., Weill Medical College of Cornell University
Phone: (646) 289-5271
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in anxiety symptoms from pre-intervention to post-intervention as measured by the HAM-A.; Change in depressive symptoms from pre-intervention to post-intervention as measured by HAM-D.; Change in anxiety symptoms from pre-intervention to post-intervention as measured by the anxiety subscale of the DASS.; Change in depressive symptoms from pre-intervention to post-intervention as measured by the depression subscale of the DASS.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.